Sesen Bio Inc - ESG Rating & Company Profile powered by AI
If you work at Sesen Bio Inc and you wish to licence your ESG rating, please get in touch. This report of Sesen Bio Inc is prepared by All Street Sevva using proprietary machine learning. The analysis of Sesen Bio Inc uses data from across the internet and also from public disclosures by Sesen Bio Inc.
Sesen Bio Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.0, social score of 1.6 and governance score of 4.8.
2.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1353 | Vera Therapeutics Inc | 2.9 | Medium |
| 1353 | Veracyte Inc | 2.9 | Medium |
| 1393 | Sesen Bio Inc | 2.8 | Medium |
| 1393 | Bioventix PLC | 2.8 | Medium |
| 1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Sesen Bio Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Sesen Bio Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Sesen Bio Inc report the average age of the workforce?
Sign up for free to unlockDoes Sesen Bio Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Sesen Bio Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Sesen Bio Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Sesen Bio Inc offer flexible work?
Sign up for free to unlockDoes Sesen Bio Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Sesen Bio Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Sesen Bio Inc conduct supply chain audits?
Sign up for free to unlockDoes Sesen Bio Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Sesen Bio Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Sesen Bio Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Sesen Bio Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Sesen Bio Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Sesen Bio Inc disclose water use targets?
Sign up for free to unlockDoes Sesen Bio Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Sesen Bio Inc have a product recall in the last two years?
Sign up for free to unlockDoes Sesen Bio Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Sesen Bio Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Sesen Bio Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Sesen Bio Inc disclose parental leave metrics?
Sign up for free to unlockDoes Sesen Bio Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Sesen Bio Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Sesen Bio Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Sesen Bio Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Sesen Bio Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Sesen Bio Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Sesen Bio Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Sesen Bio Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Sesen Bio Inc disclose its waste policy?
Sign up for free to unlockDoes Sesen Bio Inc report according to TCFD requirements?
Sign up for free to unlockDoes Sesen Bio Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Sesen Bio Inc disclose energy use targets?
Sign up for free to unlockDoes Sesen Bio Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Sesen Bio Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Sesen Bio Inc
These potential risks are based on the size, segment and geographies of the company.
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscle invasive carcinoma in situ of the bladder in patients previously treated with BCG; and for the treatment of squamous cell carcinoma of the head and neck, as well as VB6-845d, a product candidate for use in the treatment of various types of an anti-epithelial cell adhesion molecule-positive solid tumors. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc. in May 2018. Sesen Bio, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.